Comprehensive lab panel guide — what to order before starting GLP-1
Pinned because it affects plans people have already made, not because it is dramatic. Everything below is what is confirmed as of today.
This post is the record, and it will be edited as things change — with the change noted rather than substituted. If you have something firmer than what is here, a document or a date or a first-hand account, post it and it goes in with credit.
Read it this way:
- What is stated is confirmed; what is uncertain is marked as uncertain
- Anything time-sensitive is worth verifying yourself before you act on it
- The replies below carry the corrections, so read them before asking
Nothing here is advice about your situation, and the situation is still moving.
BethLabQueen said:Comprehensive lab panel guide — what to order before starting GLP-1 Pinned because it affects plans people have already made, not because it is…
Agreeing with BethLabQueen, and the qualification matters more than the agreement. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.
BethLabQueen said:Comprehensive lab panel guide — what to order before starting GLP-1 Pinned because it affects plans people have already made, not because it is…
I read this differently from BethLabQueen, on substance rather than tone. I would drop the "get everything" instinct further than this thread does. Every extra test is another chance at a false positive, and incidental findings have their own cost in scans, biopsies and worry.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsShort answer first, then the reasoning. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
anders_CPH said:One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you.
Same position here, arrived at the long way round. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.